These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
365 related items for PubMed ID: 30759966
1. Liver volume index predicts the risk of esophageal variceal hemorrhage in cirrhotic patients on propranolol prophylaxis. Kim BH, Chung JW, Lee CS, Jang ES, Jeong SH, Kim N, Kim JW. Korean J Intern Med; 2019 Nov; 34(6):1233-1243. PubMed ID: 30759966 [Abstract] [Full Text] [Related]
2. Non-invasive response prediction in prophylactic carvedilol therapy for cirrhotic patients with esophageal varices. Kim HY, So YH, Kim W, Ahn DW, Jung YJ, Woo H, Kim D, Kim MY, Baik SK. J Hepatol; 2019 Mar; 70(3):412-422. PubMed ID: 30389550 [Abstract] [Full Text] [Related]
3. Acute hemodynamic response to beta-blockers and prediction of long-term outcome in primary prophylaxis of variceal bleeding. Villanueva C, Aracil C, Colomo A, Hernández-Gea V, López-Balaguer JM, Alvarez-Urturi C, Torras X, Balanzó J, Guarner C. Gastroenterology; 2009 Jul; 137(1):119-28. PubMed ID: 19344721 [Abstract] [Full Text] [Related]
4. Risk and Predictors of Variceal Bleeding in Cirrhosis Patients Receiving Primary Prophylaxis With Non-Selective Beta-Blockers. Shukla R, Kramer J, Cao Y, Ying J, Tansel A, Walder A, Advani S, El-Serag HB, Kanwal F. Am J Gastroenterol; 2016 Dec; 111(12):1778-1787. PubMed ID: 27670600 [Abstract] [Full Text] [Related]
6. Beta-blockers for prophylaxis of bleeding from esophageal varices in cirrhotic portal hypertension. Review of the literature. Zoller WG, Gross M. Eur J Med Res; 1996 Jun 25; 1(9):407-16. PubMed ID: 9353240 [Abstract] [Full Text] [Related]
7. Beta-blockers or Placebo for Primary Prophylaxis (BOPPP) of oesophageal varices: study protocol for a randomised controlled trial. Patel VC, McPhail MJ, Uddin R, Jafari H, Lawrence V, Le Boutillier C, Shearer J, Yaziji N, Cape A, Ahmed H, Ward C, Walsh P, Besly K, Zamalloa A, Kelly J, BOPPP study group, Carter B. Trials; 2024 Apr 16; 25(1):265. PubMed ID: 38627804 [Abstract] [Full Text] [Related]
8. Effect of Nonselective β-Blockers on Mortality in Patients With End-Stage Cirrhosis. Snoga JL, Lusk KA, Attridge RT, Attridge RL. Ann Pharmacother; 2020 Apr 16; 54(4):322-330. PubMed ID: 31701773 [Abstract] [Full Text] [Related]
9. Randomized study comparing banding and propranolol to prevent initial variceal hemorrhage in cirrhotics with high-risk esophageal varices. Jutabha R, Jensen DM, Martin P, Savides T, Han SH, Gornbein J. Gastroenterology; 2005 Apr 16; 128(4):870-81. PubMed ID: 15825071 [Abstract] [Full Text] [Related]
10. Pharmacologic prevention of variceal bleeding and rebleeding. Baiges A, Hernández-Gea V, Bosch J. Hepatol Int; 2018 Feb 16; 12(Suppl 1):68-80. PubMed ID: 29210030 [Abstract] [Full Text] [Related]
11. Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis. Ripoll C, Groszmann R, Garcia-Tsao G, Grace N, Burroughs A, Planas R, Escorsell A, Garcia-Pagan JC, Makuch R, Patch D, Matloff DS, Bosch J, Portal Hypertension Collaborative Group. Gastroenterology; 2007 Aug 16; 133(2):481-8. PubMed ID: 17681169 [Abstract] [Full Text] [Related]
12. Preventing the development of varices in cirrhosis. Garcia-Tsao G. J Clin Gastroenterol; 2007 Aug 16; 41 Suppl 3():S300-4. PubMed ID: 17975480 [Abstract] [Full Text] [Related]
13. Hemodynamic response to primary prophylactic therapy with nonselective β-blockers is related to a reduction of first variceal bleeding risk in liver cirrhosis: a meta-analysis. Kerbert AJ, Chiang FW, van der Werf M, Stijnen T, Slingerland H, Verspaget HW, van Hoek B, Coenraad MJ. Eur J Gastroenterol Hepatol; 2017 Apr 16; 29(4):380-387. PubMed ID: 28002118 [Abstract] [Full Text] [Related]
14. Carvedilol for primary prophylaxis of variceal bleeding in cirrhotic patients with haemodynamic non-response to propranolol. Reiberger T, Ulbrich G, Ferlitsch A, Payer BA, Schwabl P, Pinter M, Heinisch BB, Trauner M, Kramer L, Peck-Radosavljevic M, Vienna Hepatic Hemodynamic Lab. Gut; 2013 Nov 16; 62(11):1634-41. PubMed ID: 23250049 [Abstract] [Full Text] [Related]
15. Management of betablocked patients after sustained virological response in hepatitis C cirrhosis. Abadía M, Montes ML, Ponce D, Froilán C, Romero M, Poza J, Hernández T, Fernández-Martos R, Olveira A, “La Paz Portal Hypertension” Study Group Investigators. World J Gastroenterol; 2019 Jun 07; 25(21):2665-2674. PubMed ID: 31210717 [Abstract] [Full Text] [Related]
16. EVALUATION OF PRIMARY PROPHYLAXIS WITH PROPRANOLOL AND ELASTIC BAND LIGATION IN VARICEAL BLEEDING IN CIRRHOTIC CHILDREN AND ADOLESCENTS. Pimenta JR, Ferreira AR, Bittencourt PF, Resende CB, Fagundes ED, Silva IM. Arq Gastroenterol; 2016 Jun 07; 53(4):257-261. PubMed ID: 27706456 [Abstract] [Full Text] [Related]
17. Propranolol plus endoscopic ligation for variceal bleeding in patients with significant ascites: Propensity score matching analysis. Yoo JJ, Kim SG, Kim YS, Lee B, Jeong SW, Jang JY, Lee SH, Kim HS, Jun BG, Kim YD, Cheon GJ. Medicine (Baltimore); 2020 Jan 07; 99(5):e18913. PubMed ID: 32000397 [Abstract] [Full Text] [Related]
18. Prevention of first variceal bleeding: new prospects. Hamid S, Jafri W. J Pak Med Assoc; 1992 Feb 07; 42(2):47-51. PubMed ID: 1349361 [No Abstract] [Full Text] [Related]
19. Long term effects of propranolol on portal pressure in cirrhotic patients. Orban-Schiopu AM, Popescu CR. Rom J Gastroenterol; 2003 Mar 07; 12(1):25-30. PubMed ID: 12673376 [Abstract] [Full Text] [Related]
20. Oesophageal varices in cirrhotic patients: from variceal screening to primary prophylaxis of the first oesophageal variceal bleeding. Zhang C, Thabut D, Kamath PS, Shah VH. Liver Int; 2011 Jan 07; 31(1):108-19. PubMed ID: 20946450 [Abstract] [Full Text] [Related] Page: [Next] [New Search]